M. Jonzier-Perey

发表

Dextromethorphan and Mephenytoin Phenotyping of Patients Treated with Thioridazine or Amitriptyline

P. Baumann, M. Amey, B. Woggon, 1992, Therapeutic drug monitoring.

Cytochrome P-450 activities in human and rat brain microsomes

C. Bouras, R. Janzer, C. Eap, 2000, Brain Research.

GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin.

P. Baumann, M. Jonzier-Perey, 1988, Clinica chimica acta; international journal of clinical chemistry.

Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline.

P. Baumann, M. Jonzier-Perey, L. Koeb, 1986, International clinical psychopharmacology.

Multicenter Study on the Clinical Effectiveness, Pharmacokinetics, and Pharmacogenetics of Mirtazapine in Depression

C. Eap, P. Vandel, H. Hilleret, 2012, Journal of clinical psychopharmacology.

Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.

C. Eap, S. Bender, M. Gastpar, 2000, Therapeutic drug monitoring.

Levomepromazine — a substrate of cytochrome CYP2D6?

H. Möller, P. Baumann, M. Rao, 1994, European Neuropsychopharmacology.

Mirtazapine Enantiomers in Blood and Cerebrospinal Fluid

P. Baumann, E. Paus, M. Jonzier-Perey, 2007, Neuropsychobiology.

Chirality in the New Generation of Antidepressants: Stereoselective Analysis of the Enantiomers of Mirtazapine, N-Demethylmirtazapine, and 8-Hydroxymirtazapine by LC-MS

C. Eap, P. Baumann, E. Paus, 2004, Therapeutic drug monitoring.

Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies

J. Gaillard, C. Bouras, P. Baumann, 2004, Psychopharmacology.

Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.

P. Baumann, M. Jonzier-Perey, L. Koeb, 1986, International clinical psychopharmacology.

Nonresponse to Clozapine and Ultrarapid CYP1A2 Activity: Clinical Data and Analysis of CYP1A2 Gene

C. Eap, S. Bender, F. Broly, 2004, Journal of clinical psychopharmacology.

N-methylation of maprotiline in debrisoquine/mephenitoin-phenotyped depressive patients

P. Baumann, B. Woggon, M. Jonzier-Perey, 1985 .

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.

P. Baumann, M. Amey, R. Nil, 1996, Journal of clinical psychopharmacology.

Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour

J. Ahlner, M. Reis, F. Bengtsson, 2009, Clinical pharmacokinetics.

Interindividual differences in the binding of antidepressives to plasma proteins: the role of the variants of alpha1-acid glycoprotein

M. Conti, P. Baumann, M. Jonzier-Perey, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetic Drug Interaction Potential of Risperidone With Cytochrome P450 Isozymes as Assessed by the Dextromethorphan, the Caffeine, and the Mephenytoin Test

C. Eap, G. Bondolfi, D. Zullino, 2001, Therapeutic drug monitoring.

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes

P. Baumann, K. Nill, D. Baettig, 1992, Clinical pharmacology and therapeutics.